Return On Equity in % of Cyclerion Therapeutics, Inc. from Q3 2024 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cyclerion Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2024 to Q3 2025.
  • Cyclerion Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2025 was -24.6 %, a 55.5% increase year-over-year.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)

Cyclerion Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -24.6 +30.7 +55.5% Jul 1, 2025 Sep 30, 2025
Q2 2025 -22.6 Apr 1, 2025 Jun 30, 2025
Q1 2025 -34 Jan 1, 2025 Mar 31, 2025
Q4 2024 -34.2 Oct 1, 2024 Dec 31, 2024
Q3 2024 -55.3 Jul 1, 2024 Sep 30, 2024

Cyclerion Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -34.2 Jan 1, 2024 Dec 31, 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.